New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Neoscriber Demo Publisher

Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery

Maryam Ardeshiri 1 , Zahra Faritus 1 , * , Zahra Ojaghi-Haghighi 2 , Hooman Bakhshandeh 1 , Faranak Kargar 1 and Rokhsareh Aghili 3
Authors Information
1 Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
2 Echocardiography Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences Tehran, IR Iran
3 Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Research in Cardiovascular Medicine: August 2014, 3 (3); e20270
  • Published Online: August 5, 2014
  • Article Type: Research Article
  • Received: May 16, 2014
  • Revised: June 10, 2014
  • Accepted: June 27, 2014
  • DOI: 10.5812/cardiovascmed.20270

To Cite: Ardeshiri M, Faritus Z, Ojaghi-Haghighi Z, Bakhshandeh H, Kargar F, et al. Impact of Metabolic Syndrome on Mortality and Morbidity After Coronary Artery Bypass Grafting Surgery, Res Cardiovasc Med. 2014 ;3(3):e20270. doi: 10.5812/cardiovascmed.20270.

Abstract
Copyright: Copyright © 2014, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28(11): 2745-9[PubMed]
  • 2. Sarrafzadegan N, Kelishadi R, Baghaei A, Hussein Sadri G, Malekafzali H, Mohammadifard N, et al. Metabolic syndrome: an emerging public health problem in Iranian women: Isfahan Healthy Heart Program. Int J Cardiol. 2008; 131(1): 90-6[DOI][PubMed]
  • 3. Janghorbani M, Amini M. Metabolic syndrome in type 2 diabetes mellitus in isfahan, iran: prevalence and risk factors. Metab Syndr Relat Disord. 2007; 5(3): 243-54[DOI][PubMed]
  • 4. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2003; 61(1): 29-37[PubMed]
  • 5. Hadaegh F, Zabetian A, Tohidi M, Ghasemi A, Sheikholeslami F, Azizi F. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore. 2009; 38(2): 142-9[PubMed]
  • 6. Metabolic syndrome and its relevance to Asia. Int Congr Ser. : 535-7
  • 7. Yilmaz MB, Guray U, Guray Y, Biyikoglu SF, Tandogan I, Sasmaz H, et al. Metabolic syndrome negatively impacts early patency of saphenous vein grafts. Coron Artery Dis. 2006; 17(1): 41-4[PubMed]
  • 8. Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract. 2008; 80(2): 328-34[DOI][PubMed]
  • 9. Ivanovic B, Tadic M, Bradic Z, Zivkovic N, Stanisavljevic D, Celic V. The Influence of the Metabolic Syndrome on Atrial Fibrillation Occurrence and Outcome after Coronary Bypass Surgery: A 3-Year Follow-up Study. Thorac Cardiovasc Surg. 2014; [DOI][PubMed]
  • 10. Yaginuma K, Kasai T, Miyauchi K, Kajimoto K, Amano A, Daida H. Propensity score analysis of 10-year long-term outcome after bypass surgery or plain old balloon angioplasty in patients with metabolic syndrome. Int Heart J. 2011; 52(6): 372-6[PubMed]
  • 11. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005; 28(2): 385-90[PubMed]
  • 12. Kasai T, Miyauchi K, Kajimoto K, Kubota N, Yanagisawa N, Amano A, et al. Relationship between the metabolic syndrome and the incidence of stroke after complete coronary revascularization over a 10-year follow-up period. Atherosclerosis. 2009; 207(1): 195-9[DOI][PubMed]
  • 13. Sohrabi B, Yaghoubi AR, Ghaffari S. The Impact of Diabetes on Early and Midterm Outcome of Patients Undergoing Coronary Artery Bypass Grafting Surgery. Iran Cardiol Res J. 2010;
  • 14. Hallberg V, Palomaki A, Lahtela J, Voutilainen S, Tarkka M, Kataja M, et al. Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG. Cardiovasc Diabetol. 2014; 13: 25[DOI][PubMed]
  • 15. Definition WHO. diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: World Health Organization. 1999;
  • 16. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486-97[PubMed]
  • 17. Dai DF, Lin JW, Kao JH, Hsu CN, Chiang FT, Lin JL, et al. The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events. J Clin Endocrinol Metab. 2007; 92(7): 2532-7[DOI][PubMed]
  • 18. Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E. Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers. Diabetes Care. 2006; 29(6): 1363-9[DOI][PubMed]
  • 19. Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care. 2005; 28(3): 690-3[PubMed]
  • 20. Pischon T, Hu FB, Rexrode KM, Girman CJ, Manson JE, Rimm EB. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis. 2008; 197(1): 392-9[DOI][PubMed]
  • 21. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006; 97(2A): 3A-11A[DOI][PubMed]
  • 22. Echahidi N, Pibarot P, Despres JP, Daigle JM, Mohty D, Voisine P, et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol. 2007; 50(9): 843-51[DOI][PubMed]
  • 23. Brackbill ML, Sytsma CS, Sykes K. Perioperative outcomes of coronary artery bypass grafting: effects of metabolic syndrome and patient's sex. Am J Crit Care. 2009; 18(5): 468-73[DOI][PubMed]
  • 24. Rami Helvaci M, Kaya H, Gundogdu M. Gender differences in patients with metabolic syndrome in coronary artery interventions. Med Glas (Zenica). 2013; 10(1): 75-80[PubMed]
  • 25. Kajimoto K, Miyauchi K, Kasai T, Yanagisawa N, Yamamoto T, Kikuchi K, et al. Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2009; 137(3): 658-63[DOI][PubMed]
  • 26. Ozyazicioglu A, Yalcinkaya S, Vural AH, Yumun G, Bozkurt O. Effects of metabolic syndrome on early mortality and morbidity in coronary artery bypass graft patients. J Int Med Res. 2010; 38(1): 202-7[PubMed]
  • 27. Pimenta E, Passarelli O, Jr, Borelli F, Sousa MG, Gun C, Amato V, et al. Metabolic syndrome in patients undergoing coronary artery bypass graft: prevalence and a marker of morbidity/mortality during hospitalization and 30 days after hospital discharge. Arq Bras Cardiol. 2007; 88(4): 413-7[PubMed]
  • 28. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004; 164(10): 1066-76[DOI][PubMed]
  • 29. Yatskar L, Holper E, Bansilal S, Schwartzbard A, Lombardero M, Ramanathan K, et al. Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease. Atherosclerosis. 2008; 198(2): 389-95[DOI][PubMed]
  • 30. Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation. 2005; 112(21): 3247-55[DOI][PubMed]
  • 31. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002; 40(3): 418-23[PubMed]
  • 32. Alexander CM, Landsman PB, Teutsch SM, Haffner SM, Third National H, Nutrition Examination S, et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003; 52(5): 1210-4[PubMed]
  • 33. Baslaim G, Bashore J, Alhoroub K. Impact of obesity on early outcomes after cardiac surgery: experience in a Saudi Arabian center. Ann Thorac Cardiovasc Surg. 2008; 14(6): 369-75[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader